Efficacy of augmented-dosed surgery versus botulinum toxin A injection for acute acquired concomitant esotropia: a 2-year follow-up.
Xiaoning YuWeiyi PanXiajing TangYidong ZhangLixia LouSifan ZhengKe YaoZhaohui SunPublished in: The British journal of ophthalmology (2023)
Our findings provided quantitative evidence that augmented-dosed surgery would achieve more stable and favourable surgical outcomes for AACE patients compared with BTXA injection. However, BTXA treatment is still proposed for patients with small deviation angles due to its advantages of reduced trauma, operational simplicity, low cost and quick recovery.
Keyphrases
- low cost
- minimally invasive
- botulinum toxin
- coronary artery bypass
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- ultrasound guided
- liver failure
- surgical site infection
- peritoneal dialysis
- intensive care unit
- coronary artery disease
- patient reported outcomes
- respiratory failure
- virtual reality
- percutaneous coronary intervention
- combination therapy
- replacement therapy
- patient reported